FindTrial
Sign In

Association Of Neutrophil Lymphocyte Ratio With Diabetic Retinopathy In Type 2 Diabetes Mellitus Pateints At Tertiary Care Centre.

Association Of Neutrophil Lymphocyte Ratio With Diabetic Retinopathy In Type 2 Diabetes Mellitus Patient In Tertiory Care Centre A Cross Sectional Study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/04/085078
Enrollment
60
Registered
2025-04-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E113- Type 2 diabetes mellitus with ophthalmic complications

Interventions

Intervention1: nil: nil Control Intervention1: nil: nil

Sponsors

Dr Swetha Mallika
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All diagnosed type 2 diabetes mellitus patients admitting in medicine ward of Sir T Hospital Bhavnagar during the period.

Exclusion criteria

Exclusion criteria: Acute and chronic infection conditions Drugs effecting neutrophil and lymphocyte counts Auto immune disorders Alcoholics Smokers

Design outcomes

Primary

MeasureTime frame
To assess if Neutrophil lymphocyte ratio can be used as an inflammatory marker In Diabetic Retinopathy in Type 2 Diabetic patients.Timepoint: Baseline, After 4 Weeks.—

Secondary

MeasureTime frame
To assess if neutrophil lymphocyte ratio can be used as a predictive marker in diagnosing the severity of diabetic retinopathy.Timepoint: 9months—

Countries

India

Contacts

Public ContactDr Pankaj Akholkar

Government medical college Bhavnagar

swethakrishna33@gmail.com7013979506

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026